We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.24%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.1B
AUM Growth
+$312M
Cap. Flow
-$44.8M
Cap. Flow %
-0.37%
Top 10 Hldgs %
38.76%
Holding
1,279
New
83
Increased
328
Reduced
404
Closed
81

Sector Composition

Rank Sector Weight
1 Real Estate 72.69%
2 Technology 4.79%
3 Financials 3.72%
4 Healthcare 2.91%
5 Industrials 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARX
1026
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$12K ﹤0.01%
266
-34
-11% -$1.5K
APLS
1027
DELISTED
Apellis Pharmaceuticals
APLS
$11K ﹤0.01%
361
-37
-9% -$1.02K
AUPH icon
1028
Aurinia Pharmaceuticals
AUPH
$1.96B
$11K ﹤0.01%
532
-45
-8% -$415
MYGN icon
1029
Myriad Genetics
MYGN
$515M
$11K ﹤0.01%
420
-46
-10% -$1.27K
PCRX icon
1030
Pacira BioSciences
PCRX
$1.04B
$11K ﹤0.01%
236
-26
-10% -$1.1K
XNCR icon
1031
Xencor
XNCR
$1.47B
$11K ﹤0.01%
320
-38
-11% -$1.39K
KRTX
1032
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$11K ﹤0.01%
+147
New +$6.44K
ALR
1033
DELISTED
AlerisLife Inc
ALR
$11K ﹤0.01%
+2,845
New +$13.7K
TCDA
1034
DELISTED
Tricida, Inc. Common Stock
TCDA
$11K ﹤0.01%
280
-29
-9% -$1.08K
PFPT
1035
DELISTED
Proofpoint, Inc.
PFPT
$11K ﹤0.01%
100
-13,929
-99% -$1.66M
MNTA
1036
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$11K ﹤0.01%
558
-68
-11% -$1.09K
LKFT
1037
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$10K ﹤0.01%
46
-8
-15% -$1.48K
HP icon
1038
Helmerich & Payne
HP
$3.36B
$10K ﹤0.01%
213
-4,236
-95% -$170K
HRB icon
1039
H&R Block
HRB
$5.37B
$10K ﹤0.01%
419
-7,400
-95% -$178K
LGND icon
1040
Ligand Pharmaceuticals
LGND
$5.96B
$10K ﹤0.01%
159
-38
-19% -$2.54K
M icon
1041
Macy's
M
$6.57B
$10K ﹤0.01%
607
-13,874
-96% -$217K
ITCI
1042
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$10K ﹤0.01%
302
XEC
1043
DELISTED
CIMAREX ENERGY CO
XEC
$10K ﹤0.01%
187
-3,700
-95% -$172K
PRNB
1044
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$10K ﹤0.01%
+185
New +$6.91K
PTLA
1045
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$10K ﹤0.01%
439
-55
-11% -$1.52K
ARVN icon
1046
Arvinas
ARVN
$530M
$9K ﹤0.01%
+220
New +$6.44K
BBWI icon
1047
Bath & Body Works
BBWI
$4.13B
$9K ﹤0.01%
599
-10,452
-95% -$151K
DNLI icon
1048
Denali Therapeutics
DNLI
$3.74B
$9K ﹤0.01%
542
-62
-10% -$1.03K
EDIT icon
1049
Editas Medicine
EDIT
$411M
$9K ﹤0.01%
304
ESPR
1050
DELISTED
Esperion Therapeutics
ESPR
$9K ﹤0.01%
154
-17
-10% -$764

Similar funds

Daiwa Securities Group's Q4 2019 Portfolio in Review

As of Q4 2019, Daiwa Securities Group held 1,279 positions worth $12.1B, up 2.6% from $11.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group's Q4 2019 filing shows 83 new, 328 increased, 404 reduced and 81 closed positions. Its largest new stake was Performance Food Group: 109,263 shares worth $5.63M. The largest sale was Sun Communities, an estimated $208M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q4 2019 buy was Performance Food Group: 109,263 shares worth $5.63M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q4 2019, an estimated $239M increase.
  • Daiwa Securities Group's biggest Q4 2019 reduction was Sun Communities, cutting an estimated $208M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2019, selling an estimated $13.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $12.1B portfolio in Q4 2019.
  • Daiwa Securities Group opened 83 new positions and closed 81 in Q4 2019.
  • Daiwa Securities Group's portfolio value rose 2.6% quarter-over-quarter to $12.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.